Ultrasound-Guided Treatments in Des Moines, WA

Ultrasound guidance means we use a handheld imaging device to see beneath your skin in real time, before, during, and after a procedure. Rather than relying solely on anatomical landmarks and clinical experience, we can visualize your individual vascular anatomy, tissue layers, and any existing filler deposits at the millimeter level.

The Clarius L20 HD3 operates at up to 20 MHz, making it the highest-frequency wireless ultrasound available for aesthetic medicine. In an independent University of Southern California study comparing five point-of-care ultrasound devices, the Clarius L20 HD3 ranked first for image quality. Its AI-powered T-Mode automatically labels facial tissue layers, including the dermis, subcutaneous fat, SMAS, and muscle, while Power Doppler technology identifies even the smallest vessels with exceptional sensitivity.

For dermal fillers, this changes the safety equation. Facial anatomy varies considerably from person to person, and vascular occlusion, the rare but serious complication where filler compromises arterial blood flow, is most likely to occur in patients whose vessels run in unexpected locations. Before placing any filler, we map your arteries and veins, identify the exact depth of critical vessels, and confirm the injection plane is clear. The needle or cannula stays visible on screen throughout the procedure, and we confirm vascular patency with Power Doppler when we are done.

The same imaging guides our regenerative treatments. Before every PRP joint injection, we perform a comprehensive ultrasound assessment of the joint, evaluating cartilage integrity, tendon condition, and any effusion or calcification, then guide the needle in real time to the precise site of injury. Published research, including a 2018 review in the Journal of Orthopaedic Surgery and Research, shows that ultrasound guidance increases joint injection accuracy to 90 to 95 percent or better across many anatomical targets, a significant improvement over landmark-based, unguided injections. Before a Stemwave session, we use the Clarius to confirm the precise depth and boundaries of the target tissue, so the acoustic energy is calibrated and directed to the exact site of pathology. A 2025 randomized clinical trial published in Diagnostics found that ultrasound-guided shockwave therapy produced successful outcomes in 90.9 percent of patients at six months, compared to 50 percent in the landmark-based group.

Ultrasound also lets us manage the most serious acute complication in aesthetic medicine: filler-induced vascular occlusion. Allen Medical Aesthetics accepts urgent referrals from other clinics and provides immediate, ultrasound-guided management. In a 2025 systematic review of 83 cases of filler-induced arterial ischemia, ultrasound-guided hyaluronidase injections produced rapid resolution of symptoms and restoration of vascular flow across all reported cases, and a separate clinical series of 10 patients confirmed open facial arteries and veins in 100 percent of patients, with no ulcerations or tissue necrosis. If you or your provider suspect a vascular occlusion, call us at (206) 414-9979.